Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles

Leishmaniasis is a disease caused by parasites of Leishmania sp., which effects nearly 12 million people worldwide and is associated with treatment complications due to widespread parasite resistance toward pathogen-directed therapeutics. The current treatments for visceral leishmaniasis (VL), the s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Pharm
Main Authors: Collier, M.A., Peine, K.J., Gautam, S., Oghumu, S., Varikuti, S., Borteh, H., Papenfuss, T.L., Sataoskar, A.R., Bachelder, E.M., Ainslie, K.M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5730989/
https://ncbi.nlm.nih.gov/pubmed/26768723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2016.01.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados